What is LIFE's health score?

Ethos Technologies Inc. (LIFE) has a TradeApes health score of 53 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is LIFE's estimated fair value?

Based on our 5-year discounted cash flow model, Ethos Technologies Inc.'s estimated fair value is $26.43 per share, representing a 44.5% upside from the current price. This is a model estimate, not a price target or investment recommendation.

Is LIFE undervalued or overvalued?

Our model currently rates LIFE as Undervalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

To Unlock Full Report

Create an account for unlimited access

Ethos Technologies Inc. (LIFE)

Financials Undervalued low mixed

$18.3

Updated: 2026-07-16

TradeApes Score

Financial Strength

70 Healthy

Operating Trend

40 Weak

Relative Value

55 Mixed

Capital Allocation

30 Weak

Risk Management

70 Healthy

Est. Fair Value $26.43

DCF Upside +44.5%

Sector Rank #6413 of 12160

Key Findings

+ Low leverage — net debt/EBITDA below 1×

Unlock Full Report →

− Excessive stock comp — SBC above 15% of revenue, wealth transfer to employees

Unlock Full Report →

Industry Related Stocks

Apple iSports Group, Inc. (AAPI) Enact Holdings, Inc. (ACT) AIFU Inc. (AIFU) Arthur J. Gallagher & Co. (AJG) Aon plc (AON) Accelerant Holdings (ARX)

See all Financials stocks →

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.